0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Interferons: Effectiveness, Toxicities, and Costs

Ernest C. Borden, MD; and David Parkinson, MD
[+] Article and Author Information

University of Maryland Cancer Center, Baltimore, MD 21201 National Cancer Institute, Bethesda, MD 20892 Requests for Reprints: Ernest C. Borden, MD, University of Maryland Cancer Center, 22 South Greene Street, Baltimore, MD 21201. Current Author Addresses: Dr. Borden: University of Maryland Cancer Center, 22 South Greene Street, Baltimore, MD 21201. Dr. Parkinson: Division of Cancer Treatment, National Cancer Institute, 16130 Executive Boulevard, Bethesda, MD 20892.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1996;125(7):614-615. doi:10.7326/0003-4819-125-7-199610010-00012
Text Size: A A A

Phase I, II, and III trials that defined the therapeutic effectiveness of interferons for neoplastic, viral, and immunologic diseases have helped improve the quantity and quality of life for thousands of patients. Hematologic malignant conditions have been particularly responsive to interferon treatment, but solid tumors have also been treated successfully. Interferon treatment has also decreased the duration of the symptom phases in viral diseases of DNA and RNA virus origin and have decreased the number and duration of complications of these diseases. As the use of interferons has become more widespread and duration of treatment has increased, these agents themselves have been identified as potent modifiers of biological response. Like glucocorticoids, interferons result in unwanted side effects when given in pharmacologic doses.

Topics

interferons

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)